Prevalence of Various Hemoglobinopathies-An Experience from Tertiary Care Centre
Öz
Objective:
To find out the prevalence of thalassemias and various other hemoglobinopathies
in state of Haryana and to assess the role of High performance liquid
chromatography (HPLC) for accurate and quick diagnosis of various hemoglobin
disorders.
Methods:
This study was conducted in Pt. B. D. Sharma, PGIMS, Rohtak from July 2010 to
October 2016 for hemoglobin variant screening by HPLC of total of 4275
patients, selected through multistage random sampling technique.
Results:
Among 4275 total cases surveyed, normal hemoglobin pattern was observed in 3862
(90.3%) and abnormal hemoglobin fractions on HPLC were detected in 413 (9.7%).
Βeta (β) thalassemia trait was predominant abnormality found in a total of 318
cases (7.4%). There were 19 cases of β-thalassemia major and 24 of
β-thalassemia intermedia. Other abnormal patterns found were HbE (trait in 11
and HbE disease in 6 cases), Hb S (2 cases each of sickle cell disease and
sickle cell trait), 2 cases of high Hb F (1 case each of heterozygous and
homozygous HPFH), 11 cases of Hb D Punjab along with 2 cases of Hb D Iran, 1
case of Hb C and 2 cases each of double heterozygotes for Hb E/ β-thalassemia
and Hb S/ β-thalassemia.
Conclusion: There is high prevalence of hemoglobinopathies in this region and HPLC forms a rapid and accurate tool in early detection and management of various hemoglobinopathies.
Anahtar Kelimeler
Kaynakça
- 1. Edward J. Benz Jr. Disorders of Hemoglobin Chapter 104, in Harrision’s Principle of Internal Medicine, 18th edition, 2011; 1: 852-61.
- 2. Tyagi S, Saxena R, Choudhry VP. HPLC--how necessary is it forhaemoglobinopathy diagnosis in India? Indian J Pathol Microbiol 2003; 46: 390-3.
- 3. WHO- EXECUTIVE BOARD EB118/5, 118th Session Report by the Secretariat on Thalassemia and other hemoglobinopathies: Prevalence of Hemoglobinopathies. 11 May 2006,p1-8.
- 4. Balgir RS. The genetic burden of hemoglobinopathies with special reference to community health in India and the challenges ahead. Indian Journal of Hematology and Blood Transfusion. 2002; 20: 2-7.
- 5. Joutovsky A, Hadzi-Nesic J, Nardi M. HPLC retention time as diagnostic tool for hemoglobin variants and hemoglobinopathies: A study of 60,000 samples in clinical diagnostic laboratory. Clinical chemistry. 2004; 50: 1736-47.
- 6. Alamiry AAN, Ali TH, Majeed MN. Detection of hemoglobinopathies in hypochromic, microcytic and sickeled cell blood films by haemoglobin electrophoresis. Thi-Qar medical journal (TQMJ): 2011; 5: 139-48.
- 7. Bravo-Urquiola M, Arends A, Montilla S, et all. Advantages in the use of high performance chromatography technique for screening hemoglobinopathies in Venezuela. Invest Clin2004; 45: 309-15.
- 8. Verma P, Ghildiyal A, Verma D, et all. Prevalence of hemoglobinopathies in different regions and castes of Uttar Pradesh, India- A hospital based study. Asian J Med Sci 2015; 6: 21-5.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Sağlık Kurumları Yönetimi
Bölüm
Araştırma Makalesi
Yazarlar
Monika Gupta
Bu kişi benim
0000-0003-3438-2943
Shivani Dua
Bu kişi benim
0000-0002-4701-5934
Nisha Marwah
Bu kişi benim
0000-0002-7017-9785
Meenu Gill
Bu kişi benim
0000-0001-5913-8918
Rajeev Sen
Bu kişi benim
0000-0001-7957-5613
Yayımlanma Tarihi
11 Haziran 2019
Gönderilme Tarihi
8 Eylül 2017
Kabul Tarihi
7 Haziran 2018
Yayımlandığı Sayı
Yıl 2019 Cilt: 46 Sayı: 2